That same year The Boston Globe quoted a doctor describing three terminations following unconfirmed positive results.Īfter being presented with some of The Times’s reporting, half a dozen of the largest prenatal testing companies declined interview requests. A 2014 study found that 6 percent of patients who screened positive obtained an abortion without getting another test to confirm the result. The companies have known for years that the follow-up testing doesn’t always happen. Those tests can cost thousands of dollars, come with a small risk of miscarriage and can’t be performed until later in pregnancy - in some states, past the point where abortions are legal. Patients who receive a positive result are supposed to pursue follow-up testing, which often requires a drawing of amniotic fluid or a sample of placental tissue. “I think the information they provide is misleading,” he said. office that oversees many medical tests, reviewed marketing materials from three testing companies and described them as “problematic.” does not regulate this type of test.Īlberto Gutierrez, the former director of the F.D.A. The Food and Drug Administration often requires evaluations of how frequently other consequential medical tests are right and whether shortfalls are clearly explained to patients and doctors. There are few restrictions on what test makers can offer. “The chance of breast cancer is so low, so why are you doing it? I think it’s purely a marketing thing.” “It’s a little like running mammograms on kids,” said Mary Norton, an obstetrician and geneticist at the University of California, San Francisco. The name of the person authorized to submit the NPI application or to officially change data for a health care provider.Some said the blood screenings that look for the rarest conditions are good for little more than bolstering testing companies’ bottom lines.
#CALL QUEST DIAGNOSTICS NJ WELL LICENSE#
For individual NPIs the license data is associated to the taxonomy code.
#CALL QUEST DIAGNOSTICS NJ WELL CODE#
There could be only one primary taxonomy code per NPI record. The primary taxonomy code defines the provider type, classification, and specialization. The date that a NPI record was last updated or changed. The date the provider was assigned a unique identifier (assigned an NPI). The provider other organization name codes are: The code identifying the type of other name. The other organization name is the alternative last name by which the provider is or has been known (if an individual) or other name by which the organization provider is or has been known.
These components are often separately licensed or certified by States and may exist at physical locations other than that of the hospital of which they are a component. Hospital components include outpatient departments, surgical centers, psychiatric units, and laboratories. Subparts are the components and separate physical locations of organization health care providers. 2 = Non-person: entity other than an individual human being that furnishes health care (Examples: hospital, SNF, hospital subunit, pharmacy, or HMO).1 = Person: individual human being who furnishes health care.The entity type code describes the type of health care provider that is being assigned an NPI. Quest Diagnostics Incorporated is registered as an entity type code: 2.
This address may contain the same information as the provider location address. The mailing address of the provider being identified. This address cannot include a Post Office box. For providers with more than one physical location, this is the primary location. The location address of the provider being identified. The NPI is 10-position all-numeric identification number assigned by the NPPES to uniquely identify a health care provider. What is the National Provider Indentifier (NPI)? Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings.
0 kommentar(er)
